Representation of patentee in all stages of Hatch-Waxman litigation

Represented pharmaceutical manufacturer in fast-track trial and subsequent appeal involving seven patents covering a product with annual sales of $1.4 billion. Case involved complex issues of double patenting, restriction requirements during prosecution, anticipation, and inherency. Geneva Pharm., Inc. et al. v. GlaxoSmithKline.